An indigenous apoptosis detection and measurement kit

IN595563BActive Publication Date: 2026-07-15AMITY UNIVESITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
IN201911022094
Authority / Receiving Office
IN · IN
Patent Type
Patents
Current Assignee / Owner
Filing Date
2019-06-04
Publication Date
2026-07-15
Estimated Expiration
2039-06-04

AI Technical Summary

Technical Problem

Commercially available Annexin V-based apoptosis detection kits are expensive and rely on imported products, lacking cost-effective and indigenous solutions for apoptosis detection and measurement.

Method used

Development of an indigenous apoptosis detection kit using annexin V protein cloned and expressed in a bacterial system, fused with fluorescent proteins or tagged with proprietary dyes, enabling calcium-dependent binding to phosphatidylserine for efficient apoptosis detection and quantification.

Benefits of technology

Provides a cost-effective and efficient alternative for apoptosis detection and measurement by utilizing annexin V proteins conjugated with fluorescent molecules, offering high sensitivity and ease of use while reducing reliance on imported kits.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention relates to a system and method for an indigenous apoptosis detection and measurement. The gene encoding is cloned for annexin V, express annexin V protein in bacterial expression system, either in native form or fused to fluorescent protein. Annexin V fused to fluorescent protein will be directly used to optimize tracking and quantification of cell apoptosis. Native annexin V protein will be tagged to different proprietary tagging dyes, using proprietary / open source conjugation methods, and the conjugate will be used to detect cells undergoing apoptosis and quantify them. Dated ….…day of ……...., 2019
Need to check novelty before this filing date? Find Prior Art

Description

FIELD OF INVENTION:The present invention relates to the field of apoptosis detection. The present invention in particular relates to a system and method for apoptosis detection and measurement DESCRIPTION OF THE RELATED ART:Apoptosis is an important part of the cell life cycle. It is a process of autonomic demise of cells regulated by cell death. It is important to maintain cellular and organnel homeostasis, and plays critical role in embryonic development, alternating old and new cells, normal degradation and atrophy and proliferation of some tissues. It also plays a very important role in the process of spontaneous inhibition of tumor cells. The main features of apoptosis are cell atrophy, changes in cell membrane structure, dense nuclear chromatin, and endogenous nuclease DNA degradation. Corresponding detection methods include morphological methods; methods for reflecting changes in apoptotic cell membranes, such as the Annexin V test kit imported from abroad; and methods for reflecting the regular breakage of DNA, such as DNA end labeling. Among them, the Annexin V assay is designed for the earliest features of apoptosis. In the early stages of apoptosis, cells have lost the symmetry of their membrane phospholipid compounds, and phosphatidylserine (PS) is transferred from the cell membrane to the cell membrane surface. Annexin V is a calcium-dependent phospholipid binding protein with high affinity for PS in the presence of calcium ions. Combined with fluorescent dyes and flow cytometry can be used as a sensitive probe to detect PS exposed on the surface of apoptotic cells. It is detected in the early stage of apoptosis without DNA strand breakage, and has the advantages of high cell volume, high sensitivity and quickness. Reference may be made to the following:Publication No. CN1177060 relates to a reagent kit for detecting cell wither features that its detecting protein is Annexin B1 instead of current Annexin V, resulting in high expression in colibacillus. Its other advantages are high speed and high sensitivity. The host strain XL1-Blue was first placed in 50 ml of LB medium containing 1% tryptone, 0.5% yeast extract and 1% sodium chloride, pH 7.0, and shaken at 37 ° C until the OD600 was 0.4. The mixture was centrifuged at 4000 rpm for 10 minutes at 4 ° C, and the supernatant was removed. The host bacteria were suspended in 5 ml of pre-cooled 100 mmol / L calcium chloride solution, centrifuged at 10,000 rpm for 2 minutes, and suspended in 1-2 ml of pre-cooled 100 mmol / L calcium chloride solution. ce bath for 2 hours, which is a competent bacteria. 100 ng of the constructed pJLA-Annexin B1 plasmid was mixed with the above competent bacteria and placed in an ice bath for 30 minutes.Publication No. CN102251014 relates to a cell apoptosis detection kit. By cloning the Annexing V gene of a 293 cell, the Human Annexing V gene is highly expressed in a prokaryotic cell. On the basis, an enhanced green fluorescent protein (EGFP) accesses a reading frame, and an Annexing B-EGFP fusion protein is obtained. The cell apoptosis detection kit taking the Annexing B-EGFP fusion protein as a detection protein can detect the early apoptosis of cells. Compared with the imported apoptosis detection kit, the cell apoptosis detection kit has the advantages of high efficiency, low cost and convenience in use.Publication No. CN104749145 relates to a green fluorocyte apoptosis detection kit. The green fluorocyte apoptosis detection kit comprises an outer shell, an inner pipe, a clamp ring, an upper cover and a rubber-cap dropper, wherein the outer shell is arranged on the kit, the inner pipe is located in the outer shell, the clamp ring is used for fixing the outer shell and the inner pipe, the upper over is connected with the outer shell, the rubber-cap dropper is embedded and fixed on the upper cover and comprises a rubber cap and a dropper, the rubber cap is located on the upper part of the upper cover, the dropper is located in the inner pipe, and the rubber-cap dropper is hermetically connected with the upper cover. According to the kit disclosed by the invention, the design shape of a kit in the prior art is broken through, the rubber-cap dropper is fixed on the upper cover and is connected with the upper cover into a whole so as to be convenient to extract a detection reagent, the outer shell is cylindrical so as to be convenient to place, the structure is simple, and the use is convenient.Publication No. CN104745674 relates to a one-step method TUNEL cell apoptosis detection kit. The kit comprises a kit body and a kit cover, the kit body is made of hard plastic material, a reagent liner made of hard plastic foam is placed in the kit body, a rectangular groove is formed in the reagent liner, a liquid measuring funnel box made of hard paper is stored in the groove, three liquid measuring funnels are arranged in the liquid measuring funnel box, three round grooves are formed in the reagent liner, and TdT enzyme, fluorescence labeling liquid and TdT enzyme diluent are placed in the grooves respectively. Publication No. CN104561251 relates to the field of molecular biology and medicine, and relates to a method for detecting a mutation of a cell apoptosis regenerative gene (BIM) and a detection kit thereof, and the invention provides a method for detecting a deletion of a cell apoptosis mediator gene (BIM) A method of mutation comprising detecting a 2903 bp deletion on an intron between the third and fourth exons of the BIM gene. The invention also discloses a corresponding detection kit, which further comprises a primer for amplifying a 2903 bp deletion region on BIM. By using the invention to detect the BIM deficiency, the method is simple, easy, fast, efficient, and low in cost.Patent No. US5637465 relates to a method for the detection of a programmed or induced cell death of eukaryotic cells as well as a suitable test kit for this method of detection. The label associated with the solid phase after separation of the solid from the liquid phase is a direct measure of the extent of apoptosis in the examined cell population. In each case a parallel culture of the examined cell population in which no apoptosis has been induced is used as the negative control. The label associated with the solid phase measured with this parallel culture yields the blank value for the determination. Those measured values for the label associated with the solid phase that are at least two-fold above this blank value are rated as being positive for apoptosis. If it is intended to determine apoptosis induced in vitro, the cell population to be examined is divided into two parallel preparations and then incubated in the presence or absence of the apoptosis-inducing agent (e.g. camptothecin). Publication No. US2004132049 relates to methods for the detection of apoptosis by measuring apoptotic bodies shed by apoptotic cells are provided, as are kits to carry out such methods. Nucleolin decreases in the nucleus and mis-localizes to the plasma membrane in neoplastic cells, enabling for the detection of apoptotic bodies shed into circulation. Since nucleolin is found in every nucleated cell, a convenient method for the detection of apoptotic bodies is the use of nucleolin as a marker, providing a useful method for the early detection of diseases characterized by apoptotic cell death. In addition, disease progression and evaluation of therapeutic response may be assessed using nucleolin to detect apoptosis.Publication No. CN104198720 relates to a kit for detecting apoptosis of mammalian blast cyst cells, which comprises PBS containing 0.5% BSA, PBS containing 2% Para formaldehyde, containing 0.5% Triton X-100 and 0.05% Tween20 in PBS, 10% goat serum and 0.05% Tween20 in PBS, rabbit anti-caspase-3 primary antibody, goat anti-rabbit IgG secondary antibody labeled with Alex a Fluor594 red fluoresce in, and PBS containing 20 µM H33342 liquid. The invention is mainly based on immunofluorescence technology, and targets the important caspase-3 in the process of apoptosis, and adopts antigen-antibody reaction against caspase-3 primary antibody and secondary antibody carrying fluoresces in. The apoptotic cells in the embryo were fluorescently labeled and counted; the nucleus of all the cells was stained with a DNA dye to calculate the apoptosis rate of the blast cyst cells. Publication No. CN203658264 relates to a green fluorescent cell apoptosis detection kit comprising an outer hood, an inner pipe, a snap ring, an upper cover and a rubber head dropper, wherein the outer hood is arranged on a kit body; the inner pipe is arranged inside the outer hood; the outer hood and the inner pipe are fixed by the snap ring; the upper cover is connected with the outer hood; the rubber head dropper is fixedly embedded in the upper cover, and comprises a rubber head and a dropper; the rubber head is arranged at the upper part of the upper cover; the dropper is arranged inside the inner pipe; the rubber head dropper is tightly connected with the upper cover.Publication No. CN203653568 relates to a one-step method TUNEL (Terminal-deoxynucleoitidyl Transferase Mediated Nick End Labeling) apoptosis detection kit which comprises a box body and a box cover, wherein the box body is made of a hard plastic material; the box body is internally provided with a reagent pad made of hard plastic foam; a rectangular groove is formed in the reagent pad; the groove is used for holding a liquid measuring funnel box made of hard paper; the liquid measuring funnel box is provided with three liquid measuring funnels; three circular grooves are further formed in the reagent pad; TdT enzyme, a fluorescence labeling liquid and a TdT enzyme diluent are respectively put into the grooves. The one-step method TUNEL apoptosis detection kit has the beneficial effects that the use is rapid and convenient, the application range is wide, the measuring is precise and accurate, as the reagent pad is of slope design, words on reagent bottles are not shielded, the time for selecting reagents is greatly shortened, and meanwhile as the reagent bottle body falls into the box body, the problem that the fluorescence labeling liquids needs to be stored without light is effectively solved.Publication No. WO9217610 relates to a method and a kit for detecting apoptosis in mammalian cells. More particularly, the invention relates to a new technique for detecting apoptosis in individual cells. A method is disclosed for detecting apoptosis in mammalian cells, wherein the cells to be examined are incubated in a medium suitable for in situ nick translation, while at least one of the deoxynucleotide present in the medium has been modified such that it can be detected, and the cells, after the nick translation medium has been removed, are examined for the presence of DNA containing modified deoxynucleotide. Further disclosed is a kit for the detection of apoptosis in mammalian cells, comprising components from which a medium suitable for in situ nick translation can be composed, including at least one deoxynucleotide that has been modified such that it can be detected, and means with which the cells, after removal of the nick translation medium, can be examined for the presence of DNA containing modified deoxynucleotide.Publication No. JP2009162564 relates to an apoptosis detection method includes a process for detecting a caspase cleavage product of Cytokeratin 18 contained in a culture of animal cells, and measures the apoptosis of the animal cells by using the amount of the caspase cleavage product in the culture as an indicator. Publication No. CN103159842 relates to single photon emission computed tomography (SPECT) and in particular relates to a Cys-Annexin V kit used for 99mTc labeling, a preparation method and application thereof in apoptosis detection. Each kit provided by the invention is prepared as follows: 25-150ug of Cys-Annexin V, 0.5-6mg of edetate, 5-40ug of tin salt and 0.1mmol of pH buffer agent. The TUNEL method is used for single-cell level apoptosis immunohistochemistry and quantitative analysis. The principle is to label the DNA cleavage site. The detailed steps are as follows: (1) The rat liver sample is fixed in formalin solution for 24 hours, then embedded in paraffin. The arrow in the figure refers to the fluorescent apoptotic body. The liver of the model mouse shows more fluorescent apoptotic bodies, while the control There are few apoptotic bodies that fluoresce in the liver of the group. This result is consistent with the results of rat liver apoptosis imaging of <99m>Tc-Cys-Annexin V labeled by the kit in Example 2 of the present invention, indicating that <99m>Tc-Cys-Annexin V labeled compound As an imaging agent, it is possible to show the apoptosis of rat liver.Publication No. CN101665537 relates to a novel apoptosis test regent and a related kit. On the basis of modern biology engineering technology, glutathione-S-transferees (GST) and human annex in V are coupled to form a novel recombinant fusion protein GPPAN-V, and the primary structure diagram of the protein is shown as attached diagram 1. Efficient expression product GPPAN-V recombinant fusion protein after being induced by coli bacillus host cell containing a GPPAN-V recombinant gene expression vector can exist in a soluble form, and GPPAN-V recombinant fusion protein with higher purity can be prepared by affinity chromatography purification. After being chemically coupled, the GPPAN-V recombinant fusion protein and the fluoresce in isothiocyanate (FITC) can form a novel apoptosis test regent FITC-GPPAN-V for testing apoptosis.The article entitled “Annexin V-AbFluor™ 488 apoptosis detection kit” by Abbkine, Inc., 2012 - 2017 talks about the abbkine Annexin V-AbFluor™ 488 Apoptosis Detection Kit contains Annexin V labeled with Abbkine proprietary green fluorescent dye AbFluor™ 488, which allows the identification and quantitation of apoptotic cells by flow cytometry or fluorescence microscopy.The article entitled “ANNEXIN V – FITC kit - apoptosis detection kit” by Beckman Coulter, Inc., 2009 talks about the annexin v-fitc Kit is an apoptosis detection kit based on the binding properties of annexin V to phosphatidylserine (PS) and on the DNA-intercalating capabilities of propidium iodide (PI). Apoptosis (or programmed cell death) was discovered in tissues on the basis of morphological changes of the cell. Gradually, the morphological criteria for apoptosis, like cell shrinkage, nuclear condensation and pyknosis, were complemented with biochemical criteria such as the cleavage of DNA between the nucleosomes, resulting in the ladder appearance of DNA on agarose gels. Until recently, this typical feature was considered the hallmark of apoptosis.The article entitled “ApopTag® peroxidase in situ apoptosis detection kit” by Merckmillipore, 2019 talks about the apoptosis detection kit detects apoptotic cells in situ by labeling and detecting DNA strand breaks by the TUNEL method. The kit provides sufficient reagents for immunoperoxidase staining of 40 samples. Results are visualized using brightfield microscopy. DNA fragmentation is usually associated with ultrastructural changes in cellular morphology in apoptosis (26, 38). In a number of well-researched model systems, large fragments of 300 kb and 50 kb are first produced by endonucleolytic degradation of higher-order chromatin structural organization.The article entitled “TACSTM annexin v-biotin” by Resources talks about the assay tacs Annexin V-Biotin Apoptosis Detection kit uses an Annexin V-Biotin conjugate for flow cytometry or in situ detection of cell surface changes that occur early in the apoptotic process. The Annexin V-Biotin conjugate offers the option of fluorophore selection for fluorimetric detection of apoptotic cells. Annexin V is an anticoagulant protein that preferentially binds negatively charged phospholipids. It is normal to see bright propidium iodide cells, as well as lightly counterstained propidium iodide cells. Decreasing the propidium iodide concentration in the labeling reaction may produce better results in some cells.The article entitled “Annexin V apoptosis detection kit” by Lifescience, 2019 talks about the annexin v apoptosis detection kits are a convenient, easy-to-use and safe method for Apoptosis Detection. Annexins are a family of calcium-dependent phospholipid-binding proteins, which bind to phosphatidylserine (PS). Externalization of phosphatidylserine residues on the outer plasma membrane of apoptotic cells allows detection via Annexin V. Once the apoptotic cells are bound with labelled Annexin V, it can be visualized with fluorescent microscopy or cytometry.The article entitled “Expression and purification of recombinant annexin V for the detection of membrane alterations on apoptotic cells” by Gabriela Brumatti, Clare Sheridan, Seamus Martin, Researchgate, April 2008 talks about the apoptosis is a mode of cell death that is accompanied by specific alterations to plasma membrane that promote the recognition and engulfment of these cells by phagocytes. Although several such membrane alterations have been defined, redistribution of phosphatidylserine from the inner to the outer plasma membrane leaflet has become one of the most widely used markers for apoptotic cells in mammals. This is largely due to the availability of a sensitive and specific probe for this event in the form of the phosphatidylserine-binding protein, annexin V. Here, we describe methods for the expression and purification of recombinant polyhistidine-tagged annexin V from Escherichia coli.Of note, the commercially available Annexin V test kits are all imported products, hence are quite expensive and these kits mainly includes fluorescently labeled detection protein Annexin V, DNA dye and corresponding buffer system. In order to overcome above listed prior art, the present invention aims to provide an indigenous annexin V-based apoptosis detection kit conjugated with furochromes using proprietary molecules and / or conjugation methods. While binding of our fluorescent annexin V proteins will utilize calcium dependent binding to phosphatidyl serine exposed on the surface of cells undergoing apoptosis, unique features of our annexin V fluorescent fusion molecules or tagged fluorescent molecules make our invention different from prior art.OBJECTS OF THE INVENTION:The principal object of the present invention is to provide a an indigenous apoptosis detection kit Another object of the present invention is to provide simple and easy to use apoptosis detection kitAt the outset of the description that follows, it is to be understood that the ensuing description only illustrates a particular form of this invention. However, such a particular form is only an exemplary embodiment and is not intended to be taken restrictively to imply any limitation on the scope of the present invention. BREIF DESCRIPTION OF THE INVENTION:The present invention relates to a system and method for an indigenous apoptosis detection and measurement. The gene encoding is cloned for annexin V, express annexin V protein in bacterial expression system, either in native form or fused to fluorescent protein, such as red fluorescence protein, and the protein is purified. Then the protein is characterized in details. Annexin V fused to fluorescent protein will be directly used to optimize tracking and quantification of cell apoptosis. Native annexin V protein will be tagged to different proprietary tagging dyes, using proprietary / open source conjugation methods, and the conjugate will be used to detect cells undergoing apoptosis and quantify them. As mentioned before, while binding of our fluorescent annexin V proteins will utilize calcium dependent binding to phosphatidyl serine exposed on the surface of cells undergoing apoptosis, unique features of our annexin V fluorescent fusion molecules or tagged fluorescent molecules make our invention different from prior art.The present invention expresses annexinV tagged to FLAG peptide tag for affinity purification. The expressed protein will thereafter be conjugated with fluorescent protein, such as red-fluorescence protein, or proprietary furochromes using conjugation methods to develop a highly efficient and cost-effective alternative to present apoptosis detection and measurement kits.BREIF DESCRIPTION OF THE DRAWINGS:It is to be noted, however, that the appended drawings illustrate only typical embodiments of this invention and are therefore not to be considered for limiting of its scope, for the invention may admit to other equally effective embodiments.Figure 1 shows a system for preparing carbon-dot tagged annexin-V protein, according to the present invention. Schematic representation of carbon dot-coupled annexin-V generation process.Figure 2 illustrates carbon nanodot synthesized (A), that when exposed to UV light show fluorescence. Fig. 2 (C) shows spectrophotogram of carbon nanodots exposed to UV light.Fig. 2 shows generation of antigen-specific anti-tumor T cells, induction of epitope-specific activation induced cell death in antigen-specific T cells and quantification of T cells undergoing apoptosis-mediated cell death, using furochrome-labeled annexin-v.DETAILED DESCRIPTION OF THE INVENTION:The present invention provides a system and method for preparing annexin-v protein coupled with fluorescent carbon dots. The present invention provides method for generating fluorescent carbon dots. The present invention also provides method for conjugating fluorescent carbon dots with annexin-V protein. The present invention also provides a method for utilizing carbon-dots coupled annexin-V for tracking cells undergoing apoptosis.Fig. 1. Schematic representation of carbon dot-coupled annexin-V generation process. In brief, auto-fluorescing carbon nanodots are synthesized, that are then conjugated with annexin-v protein. Carbon nanodots conjugated annexin-v is then utilized for tracking cells undergoing apoptosis, due to its ability to bind to phosphatidyl-serine, that gets exposed on surface of cells undergoing apoptosis.Fig. 2. Shown is carbon nanodot synthesized (A), that when exposed to UV light show fluorescence. Fig. 2 (C) shows spectrophotogram of carbon nanodots exposed to UV light.Fig. 3. Generation of antigen-specific anti-tumor T cells and characterization of epitope-specific T cells undergoing apoptosis, using furochrome tagged annexin-V. Human tumor antigen-specific anti-tumor T cells were generated by transducing human peripheral blood-derived CD8+ T cells with retro-viral vector expressing human melanoma-associated antigenic epitope, MART-127-35-specific T cell receptor (TCR). When exposed to target antigenic-epitope, besides exhibiting epitope-specific effector function, a significant fraction of antigen-specific T cells undergo apoptosis by epitope-specific Activation induced cell death (AICD). CD8+ T cells undergoing AICD were quantified by annexin-v tagged to furochrome (dye or carbon nanodots).The synthesis and coupling of carbon nanodots with annexin-V: (EDC / NHS) is disclosed below:Synthesis of Carbon Nanodots:For synthesis of carbon nanodots, 1 gm sucrose was dissolved in 4 ml water, which was added to 20 ml of Ortho phosphoric acid (88%). The solution was put in microwave oven at 100watt for 5 min. After the solution cooled down, 50 ml water was added. Carbon nanodots formed were pelleted down by centrifugation at 4000rpm for 10 min. Pellet was suspended in ethanol and centrifuged at 5000 rpm for 10 min.Coupling of carbon nanodots with annexin-V: (EDC / NHS) ChemistryFor coupling, 25 ml solution of carbon dots was made (1mg / ml) and sonicated at pH 8.0 for 30 min. To this, 30 mg Ethyl (dimethylaminopropyl) carbomideEDC) was added, followed by 10ul EDTA. To this, 10 ml ethanol was added dropwise with constant stirring. Carbon nanoparticles were pelleted down at 5000 rpm for 5 min and washed with ethanol once, pelleted at 5000 rpm for 5 min. Pellet was suspended in 20 ml ethanol solution at pH 6.0. In parallel 10 ml 0.1mM solution of annexin-V solution was made to which 4 mg EDC / NHS (Ethyl (dimethylaminopropyl) carbodiimide / N-Hydroxysuccinimide was added.Annexin-V-EDC / NHS solution was added into carbon nanoparticle solution, coupling was done by stirring for 4 hr, followed by washing at 7000 rpm for 25 min. twice with Ethanol. Synthesized conjugate was precipitated in double distilled water. Synthesized nanomaterials were characterized by electron microscopy (TEM / SEM) along with Energy Dispersive X-Ray Analysis (EDX), UV-Vis Spectroscopy, Fourier-transform infrared spectroscopy (FTIR), Raman Spectroscopy and X-ray powder diffraction (XRD). The synthesized carbon nanodots (CDs) were of size range upto 10 nm size range, and exhibited strong emission under the irradiation of UV in the wavelength range of 1250 nm to 350 nm, indicating broad photoluminescence characteristics of CDs.

Claims

WE CLAIM:

1. A method for preparing carbon nanodots comprises the steps of:a. Dissolving 1 gm sucrose in 4 ml water, and then adding to 20 ml of Ortho phosphoric acid (88%);b. Microwave the solution at 100watt for 5 min. c. Add 50 ml of water after cooling;d. Carbon nanodots formed are pelleted down by centrifugation at 4000rpm for 10 min and suspended in ethanol and centrifuged at 5000 rpm for 10 min.

2. A method as claimed in claim 1 wherein autofluorescent carbon nanodots are conjugated with annexin-v protein.

3. A method as claimed in claim 1 wherein the photoluminescent carbon nanodots synthesized can also be utilized biomarkers for disease identification, diagnosis, and targeted drug delivery for disease treatment.

4. A system for Coupling of carbon nanodots with annexin-V comprises the steps of:a. Sonicating 25 ml solution of carbon dots(1mg / ml) at pH 8.0 for 30 min; b. Adding 30 mg Ethyl (dimethylaminopropyl) carbomideEDC) followed by 10ul Ethylenediaminetetraacetic acid (EDTA); c. Adding 10 ml ethanol dropwise with constant stirring;d. Carbon nanoparticles pelleted down at 5000 rpm for 5 min and washed with ethanol once, again pelleted at 5000 rpm for 5 min. and suspended in 20 ml ethanol solution at pH 6.0; e. In parallel 10 ml 0.1mM solution of annexin-V solution made and added 4mg EDC / NHS (Ethyl (dimethylaminopropyl) carbodiimide / N-Hydroxysuccinimide;f. Adding Annexin-V-EDC / NHS solution into carbon nanoparticle solution, coupling by stirring for 4 hr, followed by washing at 7000 rpm for 25 min. twice with Ethanol; g. Precipitate Synthesized conjugate in double distilled water.

5. A system as claimed in claim 3 wherein carbon-nanodot conjugated anexin-v protein are utilized to track cells undergoing apoptosis.